Kidney Cancer Drugs Market Scope And Analysis

  • Report Code : TIPRE00003834
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse de la dynamique et de la portée du marché des médicaments contre le cancer du rein d'ici 2025-2031

Buy Now

Kidney Cancer Drugs Market Report Kidney Cancer Drugs Market Size and Share Kidney Cancer Drugs Market Scope and Analysis

Kidney Cancer Drugs Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 5%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Classe thérapeutique
  • thérapie ciblée
  • immunothérapie
By Classe pharmacologique
  • inhibiteurs de l'angiogenèse
  • inhibiteurs de MTOR
  • anticorps monoclonaux
  • immunothérapie par cytokines
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • Genentech, Inc
  • Bristol-Myers Squibb Company
  • Exelixis, Inc.
  • Eisai Inc
  • Active Biotech AB
  • GlaxoSmithKline plc